Trontinemab

• CAT Number: I040846
• CAS Number: 2568868-35-7
• Purity: ≥95%

Trontinemab(CAT: I040846) is a bispecific antibody designed to facilitate targeted drug delivery across the blood-brain barrier (BBB). Engineered using a transferrin receptor-mediated transport mechanism, it enhances brain penetration, making it a promising therapeutic candidate for neurological diseases. Trontinemab is being investigated for its potential in treating neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease by efficiently delivering biologics to the central nervous system. With its innovative design, Trontinemab overcomes traditional challenges in brain-targeted drug development, offering new possibilities for advancing treatments in neurology and neuroimmunology research.